Advertisement
Review Article| Volume 5, ISSUE 1, P93-106, May 2023

Download started.

Ok

Peripheral Arterial Disease in Primary Care

      Keywords

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Advances in Family Practice Nursing
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • National Heart
        Lung, Blood Institute. What is peripheral artery disease?.
        (Updated March 24, 2022. Available at:) (Accessed October 29, 2022)
        • Tsao C.W.
        • Aday A.W.
        • Almarzooq Z.I.
        • et al.
        Heart disease and stroke statistics-2022 update: a report from the American heart association.
        Circulation. 2022; 145: e153-e639
        • Criqui M.H.
        • Matsushita K.
        • Aboyans V.
        • et al.
        Lower extremity peripheral artery disease: contemporary epidemiology, management gaps, and future directions: A scientific statement from the American Heart Association.
        Circulation. 2021; 144 ([published correction appears in Circulation. 2021 Aug 31;144(9):e193]): e171-e191
        • Gerhard-Herman M.D.
        • Gornik H.L.
        • Barrett C.
        • et al.
        2016 AHA/ACC guideline on the management of patients with lower extremity peripheral artery disease: executive summary: a report of the american college of cardiology/american heart association task force on clinical practice guidelines.
        J Am Coll Cardiol. 2017; 69: 1465-1508
        • American Heart Association
        PAD roundtable report. a vascular disease thought leaders’ summit report 2019.
        (Available at:) (Published 2019. Accessed October 29, 2022)
        • The American Heart Association
        PAD National Action Plan: Executive Summary.
        (Available at:) (Accessed October 2022)
        • Minc S.D.
        • Goodney P.P.
        • Misra R.
        • et al.
        The effect of rurality on the risk of primary amputation is amplified by race.
        J Vasc Surg. 2020; 72: 1011-1017
        • Arya S.
        • Binney Z.
        • Khakharia A.
        • et al.
        Race and social economic status independently affect risk of major amputation in peripheral artery disease.
        J Am Heart Assoc. 2018; 7: e007425
        • Wu A.
        • Coresh J.
        • Selvin E.
        • et al.
        Lower extremity peripheral artery disease and quality of life among older individuals in the community.
        J Am Heart Assoc. 2017; 6: e004519
        • O'Donnell T.F.
        • Powell C.
        • Deery S.E.
        • et al.
        Regional variation in racial disparities among patients with peripheral artery disease.
        J Vasc Surg. 2018; 68: 519-526
        • Mustapha J.
        • Fisher B.T.
        • Rizzo J.A.
        • et al.
        Explaining racial disparities in amputation rates for the treatment of peripheral artery disease (PAD) using decomposition methods.
        J Racial Ethnic Health Disparities. 2017; 4: 784-795
        • Golledge J.
        • Leicht A.S.
        • Yip L.
        • et al.
        Relationship between disease specific quality of life measures, physical performance, and activity in people with intermittent claudication caused by peripheral artery disease.
        Eur J Vasc Endovasc Surg. 2020; 59: 957-964
        • Kohn C.G.
        • Alberts M.J.
        • Peacock W.F.
        • et al.
        Cost and inpatient burden of peripheral artery disease: Findings from the National Inpatient Sample.
        Atherosclerosis. 2019; 286: 142-146
        • Mustapha J.A.
        • Katzen B.T.
        • Neville R.F.
        • et al.
        Determinants of long-term outcomes and costs in the management of critical limb ischemia: a population-based cohort study.
        J Am Heart Assoc. 2018; 7 (e009724: 1-11)
        • Creager M.A.
        • Loscalzo J.
        Arterial Diseases of the Extremities.
        in: Jameson J. Fauci A.S. Kasper D.L. Harrison's principles of internal medicine. 20th edition. McGraw Hill, 2018 (Available at:) (Accessed October 29, 2022)
        • Libby P.
        • Buring J.E.
        • Badimon L.
        • et al.
        Atheroscler Nat Rev Dis Primers.
        . 2019; 5: 1-18https://doi.org/10.1038/s41572-019-0106-z
        • Gasper W.J.
        • Iannuzzi J.C.
        • Johnson M.D.
        Occlusive disease: femoral & popliteal arteries.
        in: Papadakis M.A. McPhee S.J. Rabow M.W. Current medical diagnosis & treatment 2022. McGraw Hill, 2022 (Available at:) (Accessed August 21, 2022)
        • Smith D.K.
        • Arnold M.J.
        • Larson J.
        How to refine your approach to peripheral arterial disease.
        J Fam Pract. 2020; 69: 500-506
        • McDermott M.M.
        Medical management of functional impairment in peripheral artery disease: A review.
        Prog Cardiovasc Dis. 2018; 60: 586-592
        • Klarin D.
        • Lynch J.
        • Aragam K.
        • et al.
        Genome-wide association study of peripheral artery disease in the Million Veteran Program.
        Nat Med. 2019; 25: 1274-1279
        • Hardman R.L.
        • Jazaeri O.
        • Yi J.
        • et al.
        Overview of classification systems in peripheral artery disease.
        Semin Intervent Radiol. 2014; 31: 378-388
        • Rutherford R.B.
        • Baker J.D.
        • Ernst C.
        • et al.
        Recommended standards for reports dealing with lower extremity ischemia: revised version.
        J Vasc Surg. 1997; 26 ([published correction appears in J Vasc Surg 2001 Apr;33(4):805]): 517-538
        • Kullo I.J.
        • Rooke T.W.
        Peripheral Artery Disease.
        N Engl J Med. 2016; 374: 861-871
        • Mattioli A.V.
        • Coppi F.
        • Migaldi M.
        • et al.
        Relationship between Mediterranean diet and asymptomatic peripheral arterial disease in a population of pre-menopausal women.
        Nutr Metab Cardiovasc Dis. 2017; 27: 985-990
        • Ruiz-Canela M.
        • Estruch R.
        • Corella D.
        • et al.
        Association of Mediterranean diet with peripheral artery disease: the PREDIMED randomized trial.
        JAMA. 2014; 311: 415-417
        • Sutton M.
        • Kreider K.
        • Thompson J.
        • et al.
        Improving outcomes in patients with peripheral arterial disease.
        J Vasc Nurs. 2018; 36: 166-172https://doi.org/10.1016/j.jvn.2018.06.005
        • Center for Disease Control and Prevention (CDC)
        Smoking & tobacco use: how to quit.
        (Available at:) (June 17, 2021. Accessed October 29)
        • Centers for Medicare & Medicaid Services
        Supervised exercise therapy (SET) for symptomatic peripheral artery disease (PAD). decision summary.
        (Available at:) (Accessed September 21, 2022)
      1. Pletal (cilostazol) [package insert]. Otsuka Pharmaceutical, Inc, Rockville, MD2015 (Available at:) (Accessed October 27, 2022)
        • Arnett D.K.
        • Blumenthal R.S.
        • Albert M.A.
        • et al.
        2019 ACC/AHA guideline on the primary prevention of cardiovascular disease: Executive summary.
        Circulation. 2019; 140: e563-e595
        • Carey R.M.
        • Whelton P.K.
        2017 ACC/AHA hypertension guideline writing committee. prevention, detection, evaluation, and management of high blood pressure in adults: synopsis of the 2017 american college of cardiology/american heart association hypertension guideline.
        Ann Intern Med. 2018; 168: 351-358
        • American Diabetes Association
        Standards of medical care in diabetes – 2022 abridged for primary care providers.
        Clin Diabetes. 2022; 40: 10-38